Ronald W. Brower

RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION

M Verstraete, M Bory, D Collen et al. · The Lancet · 1985 · 752 citations

Thrombosis, Cardiovascular Disease, Fibrinolysis +10

Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty.

Patrick W. Serruys, William Wijns, Marcel van den Brand et al. · Circulation · 1984 · 286 citations

Hypertension, Heart Failure, Surgery +19

Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function.

David M. Leaman, Ronald W. Brower, Geert T. Meester et al. · Circulation · 1981 · 241 citations

Vascular Disease, Cardiovascular Disease, Coronary Artery Disease +9

DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTION

M Verstraete, Ronald W. Brower, D Collen et al. · The Lancet · 1985 · 240 citations

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate

Marc Verstraete, Alfred Arnold, Ronald W. Brower et al. · The American Journal of Cardiology · 1987 · 115 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Acute Coronary Thrombolysis +13